B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Bx 795

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bx 795, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cerdulatinib
2 shared targets
amlexanox
3 shared targets · score 46.9
adavosertib
2 shared targets
orantinib
2 shared targets
momelotinib
2 shared targets
pacritinib
2 shared targets
pf
3 shared targets
silmitasertib
2 shared targets
gsk
3 shared targets
pha
5 shared targets
Loading evidence profile...

This evidence profile for Bx 795 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.